Emergent BioSolutions to Release Third Quarter 2020 Financial Results and Conduct Conference Call on November 5, 2020

Rhea-AI Summary

Emergent BioSolutions (EBS) will host a conference call on November 5, 2020, at 5:00 PM ET, to discuss Q3 2020 financial results, recent business developments, and revenue guidance for Q4 2020 and full year 2020. The call can be accessed via telephone or live webcast. Details including dial-in numbers and conference ID are provided in the release. The company aims to enhance life through specialty products and services, aspiring to protect or enhance 1 billion lives by 2030.

Positive

• The conference call will detail revenue guidance for Q4 2020 and the full year, indicating proactive financial communication.
• Emergent BioSolutions aims to protect or enhance 1 billion lives by 2030, showing a long-term commitment to public health.

Negative

• None.

GAITHERSBURG, Md., Oct. 15, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, November 5, 2020 at 5:00 pm (Eastern Time) to discuss the financial results for the third quarter of 2020, recent business developments, revenue guidance for the fourth quarter of 2020, and financial outlook for full year 2020.

This conference call can be accessed live by telephone or by webcast:

Live Teleconference Information:
Dial in number: (855) 766-6521
International dial in number: (262) 912-6157
Conference ID: 3549944

Live Webcast Information:
Visit https://edge.media-server.com/mmc/p/7c8i4shm for the live webcast feed.

A replay of the call can be accessed on Emergent’s website emergentbiosolutions.com under “Investors.”

About Emergent BioSolutions
Emergent BioSolutions is a global life sciences company whose mission is to protect and enhance life. Through our specialty products and contract development and manufacturing services, we are dedicated to providing solutions that address public health threats. Through social responsibility, we aim to build healthier and safer communities. We aspire to deliver peace of mind to our patients and customers so they can focus on what’s most important in their lives. In working together, we envision protecting or enhancing 1 billion lives by 2030. For more information visit www.emergentbiosolutions.com. Find us on LinkedIn and follow us on Twitter @emergentbiosolu and Instagram @life_at_emergent.

Investor Contact:
Robert G. Burrows
Vice President, Investor Relations
240-631-3280
BurrowsR@ebsi.com

Media Contact:
Miko B. Neri
Senior Director, Global Communications & Public Affairs
240-631-3392
NeriM@ebsi.com

FAQ

When is Emergent BioSolutions' Q3 2020 earnings call?

The earnings call for Q3 2020 will be held on November 5, 2020, at 5:00 PM ET.

How can I access the Emergent BioSolutions conference call?

You can access the conference call via telephone at (855) 766-6521 or via international line at (262) 912-6157. The conference ID is 3549944.

What topics will be discussed in the Emergent BioSolutions earnings call?

The call will cover Q3 2020 financial results, recent business developments, and revenue guidance for Q4 2020 and the full year 2020.

What is Emergent BioSolutions' financial outlook for 2020?

The company will provide revenue guidance for Q4 2020 and the full year during the upcoming earnings call.